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Abstract
Objectives To determine the prevalence of pulmonary embolism (PE) and alternative diagnoses detected by computed tomog-
raphy pulmonary angiography (CTPA) in pregnant women; and to assess changes over time regarding radiation dose, technical
quality, and examination frequency.
Materials and methods This retrospective study included all pregnant women referred for CTPA due to clinically suspected PE
over 17 years. Two blinded radiologists reviewed the CTPAs in consensus with regard to PE, alternative diagnoses, and technical
quality. We retrieved patient data regarding radiation dose metrics and associated clinical and laboratory parameters. Subgroup
comparisons were performed (Wilcoxon and Kruskal-Wallis tests).
Results Of the 237 identified patients, 8 (3.3%) were excluded due to inadequate technical CTPA quality, and 229 patients were
analyzed (mean age, 31.7 years; mean gestational age, 28 ± 7 weeks). The four different CT systems used over the study period
had similar technical quality (p = 0.28). Of 229 patients 16 (7%) patients had PE, 144 (62.9%) had no abnormal findings, and 69
(30.1%) had an alternative diagnosis (consolidation, other pulmonary opacities, pleural effusion, and basal atelectasis).
Gestational age, symptoms, and D-dimer levels were not significantly different between patients with or without PE
(p > 0.05). Over time, radiation dose exposure decreased by 30% (p < 0.001), while the number of annual examinations increased
by > 4-folds.
Conclusions In pregnant women, CTPA rarely indicates PE andmore often shows alternative diagnoses. Over 17 years, the use of
CTPA in pregnancy has notably increased, while the radiation dose exposure has decreased by one third.
Key Points
• The use of CTPA in pregnancy has steadily risen over the last 17 years
• In pregnant women, CTPA rarely reveals PE and more often shows alternative diagnoses
• Recent technical improvements have substantially decreased the radiation dose exposure inherent in CTPA without reducing
diagnostic image quality
Keywords Multidetector computed tomography . Computed tomography angiography . Pulmonary embolism . Hematologic
pregnancy complications
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CTDIvol Volume CT dose indexes
CTPA Computed tomography pulmonary angiography
CUS Compression ultrasound
DVT Deep vein thrombosis
MDCT Multidetector computed tomography
PE Pulmonary embolism
ROI Region of interest
SD Standard deviation
V/Q Ventilation-perfusion lung scan
VTE Venous thromboembolism
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Introduction
Pregnancy induces a prothrombotic state, with increased co-
agulation factors, decreased natural anticoagulants, and im-
pairment of fibrinolysis. This hypercoagulable state most like-
ly evolved during pregnancy to protect women from the risk
of bleeding during miscarriage and childbirth. Several factors
can increase the risk for venous thromboembolism (VTE)
during pregnancy, including inherited thrombophilia,
antiphospholipid syndrome, or previous history of thrombosis
[1–3]. Compared to the non-pregnant population, pregnancy
increases the risk of deep vein thrombosis (DVP) and pulmo-
nary embolism (PE) by at least four times. Acute VTE events
occur in 1–2 per 1000 pregnancies [3, 4]. PE is the leading
non-obstetric cause of maternal death, with death occurring in
1 of 100 pregnant women diagnosed with PE [4].
Typical PE symptoms are non-specific during pregnancy,
since normal pregnancies commonly involve dyspnea, tachy-
cardia, and leg swelling [5]. Likewise, clinical probability
scores, such as the Wells model [6] and Geneva criteria [7],
have not been validated in pregnant women [8]. Moreover, the
progression of a normal pregnancy involves a physiological
increase of D-dimer levels and current evidence suggests that
a D-dimer test—even using pregnancy-specific thresholds—
should not be used as a stand-alone test to manage pregnant
patients with suspected PE [9].
Due to these diagnostic difficulties, pregnant women with
suspected PE require additional diagnostic imaging, particu-
larly if compression ultrasound (CUS) of the legs is negative
or not indicated due to the absence of leg symptoms. Despite
well-established guidelines [10] recommending chest X-ray
followed by perfusion scintigraphy, computed tomography
pulmonary angiography (CTPA) is preferred over
ventilation-perfusion lung scan (V/Q) in most North
American [11] and European centers. CTPA has the advantage
of being available around the clock, potentially unveiling al-
ternative diagnoses [4, 12, 13].Moreover, CTPA can accurate-
ly exclude clinically significant PE in pregnancy [14]. Even
when using a low-dose protocol, CTPA is associated with
radiation exposure to the mother and the fetus; however, this
is considered warranted given the critical nature of PE [15].
In the present study, we aimed to assess the prevalence of
CTPA-detected PE in a population of pregnant women, as
well as the prevalence of associated or alternative diagnoses,
and the clinical factors associated with PE. Secondary objec-
tives included the assessment of qualitative image quality and
dose exposure over a long period.
Materials and methods
This study was approved by our institutional ethics commit-
tee, and the requirement of informed consent was waived.
Study design and patients
In this single-center tertiary care retrospective study, we per-
formed a systematic query of our computerized institutional
database to identify all of the radiological reports from patients
referred to our emergency department due to clinically
suspected acute PE. A search using the four keywords “pul-
monary embolism,” “pregnancy,” “pregnant,” and “computed
tomography” yielded records of 237 CTPAs performed in
pregnant patients from January 2000 to August 2018.
MDCT protocols
Over the study period, CTPA was performed using four dif-
ferent CT systems: a 4-row multidetector computed tomogra-
phy (MDCT) system (LightSpeed QX/I; GE Healthcare) was
used from January 2000 to November 2002 (14 examina-
tions). A 16-row MDCT system (LightSpeed Ultra; GE
Healthcare) was used from December 2002 to January 2006
(20 examinations). A 64-row MDCT system (LightSpeed
VCT; GE Healthcare) was used from February 2006 to
August 2015 (140 examinations). Finally, a 256-row MDCT
system (Revolution CT; GE Healthcare) was used from
September 2015 to August 2018 (63 examinations). Table 1
presents the detailed acquisition parameters for each of the
four MDCT systems. All examinations were performed in
helical acquisition mode. A power injector was used for intra-
venous (IV) injection of 80–120 mL iohexol (300 mg I/mL,
Accupaque® 300; GEHealthcare) into an antecubital vein at a
flow rate of 4–5 mL/s. Bolus tracking (SmartPrep) was ap-
plied, with the region of interest (ROI) centered on the main
pulmonary artery. Acquisition was triggered when the CT
attenuation exceeded 150 Hounsfield units. Patients were in
a supine position, with their arms above their head, and were
scanned from the diaphragm to the lung apices, at full inspi-
ration. Starting in December 2016 (when using the 256-row
MDCTsystem), we used three different tube potential settings
(80, 100, or 120 kVp) depending on the patient’s body mass
index (BMI): < 24, 24–26, or > 26 kg/m2, respectively. The
image reconstruction parameters were as follows: section
thickness, 2.5 mm until January 2006 and 1.25 mm from
February 2006; section overlap, 2.25 mm until January 2006
and 1 mm from February 2006; kernel, soft tissue; algorithm,
FBP; display field-of-view, adjusted to the patient’s size. We
retrieved the volume CT dose indexes (CTDIvol) and dose-
length products (DLP) from the dose exposure reports inte-
grated into the DICOM images for each MDCT examination.
Image analysis
All MDCT images were analyzed using a picture archiving and
communication system workstation (Vue PACS version 11.4;
Carestream Health) and displayed with the default soft tissue
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window (level, 50 HU; width, 350 HU). Raters were able to
change windowing as needed to optimize vessel visualization.
Each CTPA examination was reviewed by two radiologists (S.S.
and V.I.) with 14 and 4 years of experience in thoracic imaging,
respectively, who were blinded to all clinical and radiological
information. Images were reviewed in consensus and not sepa-
rately, since the interrater agreement for CTPA evaluation has
already been assessed before [13, 14, 16].
On a per-examination basis, we visually evaluated the en-
hancement quality of the pulmonary arteries by the IV-injected
contrast agent using a 4-point Likert scale: 0 = non-diagnostic
(excluded), 1 = diagnostic image with presence of severe arti-
facts, 2 = good image quality with minor artifacts, and 3 = ex-
cellent image quality with no relevant artifacts [17]. The exami-
nations were then classified as positive or negative for acute PE.
Signs of acute PE were defined as a luminal filling defect that
was either totally occlusive in a normal-sized or enlarged vessel,
or centrally located and delineated by contrast medium [18]. We
recorded the anatomical location of acute PE (i.e., main, lobar,
segmental, and sub-segmental), and measured the maximal di-
ameter of the pulmonary trunk. We also noted the following
diagnoses—pulmonary consolidation, any pulmonary opacities
other than consolidation (tree-in-bud pattern or ground-glass
opacity), basal band-like atelectasis, and pleural effusion—that
could occur in association with PE or as an alternative diagnosis
in the absence of PE.
After evaluating the CTPA images, we searched the patients’
clinical charts using a structured approach to retrieve the patients’
characteristics, history, symptoms, blood test values, and risk
factors for VTE (i.e., immobilization, obesity, thrombophilia,
previous VTE, and smoking). From the patients’ past medical
history, we retrieved data regarding underlying heart disease,
arterial hypertension, multiple gestations, parity, and use of
assisted reproductive techniques. Presenting symptoms included
sudden onset of chest pain, dyspnea, hemoptysis, desaturation
(oxygen saturation of < 90% by pulse oximetry), or uni- or
bilateral leg edema. We also recorded the following additional
clinical, laboratory, and anamnestic parameters: tachycardia
(heart rate > 110 beats/min), S1Q3T3 pattern on ECG, D-dimer
levels, CUS of the legs before CTPA, and ongoing therapeutic
anticoagulation.
Statistical analysis
All statistical analyses were performed using Stata 13.1 software
(StataCorp). Continuous variables are presented as mean ± stan-
dard deviation (SD) and categorical variables as numbers or pro-
portions. The proportions of patients with PE, an alternative di-
agnosis, and no radiological findingswere defined as the percent-
ages of patients in these three categories among the whole study
cohort. Between-group data comparisons were performed in a
two-step fashion. Firstly, we compared patients with PE to pa-
tients without PE. Secondly, we made comparisons between pa-
tients with PE, patients with an alternative diagnosis and those
with a normal CTPA (i.e., without any radiological findings).
Between-group comparisons were performed using the
Wilcoxon sign rank-sum or Kruskal-Wallis tests for continuous
variables, and Fisher’s exact test or the Chi-squared test, as ap-
propriate, for categorical variables. For variables that significant-
ly differed between groups, we performed logistic regression
analysis with computation of the odds ratio (OR) and 95% con-
fidence interval (CI). The Kruskal-Wallis test was used to com-
pare image quality and dose parameters between the fourMDCT
scanners. A p value of < 0.05 was considered statistically signif-
icant. When needed, the significance level was corrected for
multiple comparisons using the Bonferroni method.
Results
Patients and diagnoses
Of the 237 identified patients, 8 (3.3%) were excluded from
analysis due to poor technical image quality. In 7 patients
Table 1 Acquisition parameters
of the four different MDCT
systems
Parameter MDCT system
Detector configuration 4-row 16-row 64-row 256-row
Tube potential, kVp 120 120 120 80, 100, or 120*
Noise index N/A 18 18 15.5
Tube current, mA 170 180 100–300 100–580
Beam collimation, mm 4 × 3.75 16 × 1.25 64 × 0.625 128 × 0.625
Beam pitch 1.2 1.75 0.984 0.992
Gantry rotation time, s 0.8 0.5 0.6 0.5
Acquisition direction Caudocranial Caudocranial Caudocranial Craniocaudal
Number of examinations per year 4.8 6.3 14.6 21.0
MDCT multidetector computed tomography
*Depending on patient body mass index (BMI)
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(88%), the pulmonary arteries were too poorly enhanced and
in one patient, whose CTPA revealed left lower lobe pneumo-
nia, there were too many respiratory artifacts. None of these 8
excluded patients underwent further diagnostic imaging, and
they were thus considered negative for VTE. Our analysis
included a total of 229 patients with a mean age of 31.7 ±
5.7 years (range 18–49 years), and a mean gestational age of
28 ± 7 weeks (range 6–40 weeks). Among these patients, 16
(7%) had acute PE, 69 (30.1%) had an alternative diagnosis,
and 144 (62.9%) exhibited no abnormal findings upon CTPA
(Fig. 1). Clinically, pulmonary infection with/without pleural
effusion was diagnosed in 17 patients (24.6%), fluid overload
with pulmonary opacities (mostly of cardiac, renal, or septic
origin) with/without pleural effusion in 21 patients (30.4%),
basal atelectasis (mostly due to immobilization or abdominal
diseases) with/without pleural effusion in 21 patients (30.4%),
pulmonary opacities of another origin (i.e., interstitial lung
disease, ARDS) in 8 patients (11.6%), and pleural effusion
only in 2 patients (3%). Figures 2 and 3 provide examples of
acute PE with associated pulmonary infarction and pulmonary
consolidation, thus pulmonary infection, in pregnant patients.
In patients with PE, the position of the most proximal clot
was identified as proximal (n = 1), lobar (n = 4), segmental (n
= 10), or sub-segmental (n = 1). Of the 16 patients with PE, 8
had associated findings, including pulmonary opacities (n =
2), pleural effusion (n = 2), or basal atelectasis (n = 4). Among
the 213 patients without PE, 35 (16.4%) had a single alterna-
tive diagnosis, while 34 (16.0%) had multiple alternative di-
agnoses. Mean pulmonary trunk diameter was 26 ± 2.8 mm
among PE-positive patients, and 27 ± 3.7 mm among PE-
negative patients (p = 0.97). Of the 229 patients included in
the analysis, 16 (7%) underwent a chest X-ray before CTPA,
and 88 (38.4%) underwent a lower extremity CUS that
yielded negative results before CTPA. Among the 16 patients
with PE, 7 (43.8%) had a normal CUS of the lower
extremities, and 3 (18.8%) underwent a chest X-ray before
CTPA. After CTPA, perfusion scanning was performed in 8
(3.3%) of the 229 patients, but not in any patient in whom the
CTPA findings indicated PE. These perfusion scans were neg-
ative for PE except in one case where the result was inconclu-
sive because ofminor bilateral subpleural perfusion abnormal-
ities. In one patient (0.5%), CTPAwas performed following an
inconclusive perfusion scan.
Clinical characteristics associated with PE
Table 2 presents the baseline characteristics, risk factors, med-
ical history, symptoms, presence of ECG abnormalities, and
D-dimer levels for PE-positive and PE-negative patients, with
univariate comparison. None of the evaluated parameters sig-
nificantly differed between the two groups. Chest pain was
present in 93.8% of patients with PE, and 72.3% of patients
without PE, but this difference was not statistically significant
(p = 0.076). D-dimer levels did not significantly differ be-
tween the two groups (p = 0.91), as illustrated in Fig. 4.
The cohort was subdivided into three groups: PE; alterna-
tive diagnosis; and no radiological diagnosis (Table 3).
Subgroup analysis showed that desaturation was more fre-
quent in patients with positive CTPA findings, being noted
in 37.5% of PE patients, and 33.3% of patients with an alter-
native diagnosis, compared to only 13.4% of patients with no
radiological diagnosis (p = 0.001). Likewise, uni- or bilateral
leg edema was significantly more frequent in PE patients
(31.3%), than in patients with an alternative diagnosis
(8.7%) or no diagnosis (17.4%) (p = 0.045).
Logistic regression analysis revealed that desaturation pre-
dicted an abnormal CTPA (PE or an alternative diagnosis)
compared to no radiological findings (OR 3.1, 95% CI 1.6–
6.2, p < 0.001). Swelling of the legs predicted PE compared to
144
14
33
43
29
16
0 20 40 60 80 100 120 140 160
No alternative diagnosis
Consolidation
Opacities
Basal atelectasis
Pleural effusion
PE
Number of patients
Alternative CTPA diagnoses in PE-negative patientsFig. 1 Histogram shows the
computed tomography
pulmonary angiography (CTPA)
findings in the patients without
pulmonary embolism (PE) (n =
213), including alternative diag-
noses, and completely normal CT
examinations (n = 144, 67.6%)
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an alternative diagnosis (OR 4.8, 95% CI 1.2–18.4,
p = 0.023).
Image quality and dose exposure
The visually assessed technical quality of each CTPA (i.e., the
contrast medium enhancement of the pulmonary arteries) ex-
hibited a similar distribution among the four CT types (p =
0.28). The mean scores were as follows: 4-MDCT, 2.1 ± 0.7
(n = 11); 16-MDCT, 2.6 ± 0.6 (n = 20); 64-MDCT, 2.5 ± 0.7 (n =
136); and 256-MDCT, 2.5 ± 0.7 (n = 62).
Both CTDIvol and DLP significantly differed between the
four different MDCT systems (p < 0.001), showing a signifi-
cant decrease with newer systems (Fig. 5). On the other hand,
the number of CTexaminations performed annually showed a
gradual and substantial increase, ranging from 4.8 scans per
Fig. 2 Axial computed
tomography pulmonary
angiography images in the soft
tissue (a) and lung windows (b),
from a 25-year-old pregnant pa-
tient presenting with acute chest
pain. A segmental pulmonary
embolus was detected in the left
lower lobe (a, white arrow), with
associated triangular-shaped areas
of subpleural alveolar density (b,
arrowheads), consistent with pul-
monary infarction
Fig. 3 Axial computed
tomography pulmonary
angiography images in the lung
(a) and the soft tissue windows
(b), from a 33-year-old pregnant
patient presenting with acute
chest pain and dyspnea. No
pulmonary emboli were detected;
however, the scan revealed left
lower lobe consolidation
consistent with pulmonary
infection (a, black arrows)
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year with the 4-row CT system, to 21 scans per year with the
256-row system, constituting a > 4-fold rise over the last 17
years (Table 1).
Discussion
Our current results including 229 pregnant women indicate
that 7% had acute PE, 30% had alternative diagnoses, and
63% had a normal CTPA. This low prevalence of PE indicates
that CTPA was mainly useful for excluding PE in this popu-
lation. Notably, alternative, and sometimes clinically impor-
tant diagnoses were made from CTPA in one third of patients.
This was the first study to evaluate the use of CTPA for
suspected PE in pregnant women over a period of 17 years.
Over this timeframe, we observed a dramatic increase in the
number of scans performed, starting from 4.8 examinations
per year in 2000, and reaching 21 examinations per year by
2018, mirroring the results from an extensive single-center
review performed in North America [19]. In that cohort, the
rate of X-ray imaging in pregnant patients increased by
> 100% over 10 years, mostly due to the use of CT. In our
cohort, however, the rate of PE-positive CTPAs did not simul-
taneously increase over time, being 11.4% from January 2000
to November 2002, 0% from December 2002 to January
2006, 6.8% from February 2006 to August 2015, and
11.1%. from September 2015 to August 2018. Thanks to tech-
nological improvements across the study period, the total ra-
diation dose (DLP) decreased by 30% per scan, and CTDIvol
dropped by almost 60%, from 11.5 to 4.8 mGy, without cut-
ting back on image quality.
Overall, PE was diagnosed in 7% of patients, which is in
agreement with previously reported data [20–24]. This rate of
PE-positive CTPAs is about half the rate usually reported in
the general non-pregnant population, confirming the challeng-
ing nature of clinical assessment for PE during pregnancy [25,
Table 2 Characteristics, risk
factors, anamnestic parameters,
and symptoms—compared be-
tween PE-positive and PE-
negative patients by univariate
analysis
Variables PE positive (n = 16) PE negative (n = 213) p value
Characteristics
Age, years 29.8 ± 5.6 31.9 ± 5.7 0.17
Gestational age, weeks 27.3 ± 8.1 27.8 ± 7.7 0.81
Anticoagulation 0 (0.0%) 15 (7.0%) 0.61
Risk factors
Immobilization 2 (12.5%) 40 (1.9%) 0.74
Obesity 1 (6.3%) 24 (11.3%) 1.0
Thrombophilia 0 (0.0%) 10 (4.7%) 1.0
Previous VTE 0 (0.0%) 9 (4.25) 1.0
Smoking 1 (6.3%) 20 (9.4%) 1.0
History
Heart disease 0 (0.0%) 9 (4.2%) 1.0
Hypertension 0 (0.0%) 11 (5.2%) 1.0
Multiple gestations 2 (12.5%) 26 (12.2%) 1.0
Parity 0.94 ± 1.18 0.66 ± 1.05 0.27
Assisted reproductive techniques 0 (0.0%) 5 (2.3%) 1.0
Symptoms
Chest pain 15 (93.8%) 154 (72.3%) 0.076#
Dyspnea 12 (75.0%) 167 (78.4) 0.76
Hemoptysis 2 (12.5%) 6 (2.8%) 0.10
Desaturation (O2 saturation < 90%) 6 (37.5%) 43 (20.2%) 0.12
Lower extremity swelling 5 (31.3%) 31 (14.6%) 0.14
Other parameters
Tachycardia * 5 (31.3%) 48 (23.8%) 0.51
Abnormal ECG 1 (6.3%) 21/213 1.0
D-dimers, ng/mL † 2238 ± 2056 1552 ± 1241 0.91
PE pulmonary embolism, VTE venous thromboembolism, ECG electrocardiogram
†D-dimers were available in 176 (78.2%) patients, including 8 with PE and 168 without
*Heart rate information was available for 218 (95.2%) patients, including 16 with PE and 202 without
# Patients with PE tended to more commonly experience chest pain
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26]. This difficulty is highlighted by the absence of clinical
symptoms showing significant predictive value for PE.
Furthermore, no clinical or laboratory factor (Table 2) was
found to predict PE presence on CTPA. This is in agreement
with Touhami et al, who recently reported that the revised
Geneva and Wells scores are not helpful for PE prediction
[8]. Only after subdividing the cohort into 3 groups (PE
positive, alternative diagnosis, no findings on CTPA,
Table 3), desaturation appeared to be a predictor of an abnor-
mal CTPA (PE or alternative diagnosis), and leg swelling
appeared to be a predictor of PE compared to an alternative
diagnosis. Both are known signs that can be found in PE-
patients but offer little advantage in the diagnostic workup
of pregnant patients. Based on the latest prospective studies,
there is currently no consensus regarding the exact D-dimer
threshold that should be applied during pregnancy. Righini
et al [23] used a conservative threshold of 500 μg/L. Van
der Pol et al [22] used 1000 μg/L for patients not meeting
any YEARS criteria (clinical signs of DVT, hemoptysis, and
PE being the most likely diagnosis), or 500 μg/L in the pres-
ence of one or more YEARS criteria. Our results showed
equal elevation of D-dimer levels in women with and without
PE, and D-dimer levels of < 1000 μg/L in one third of our
patients with PE. These findings raise questions regarding the
reliability of higher PE-specific D-dimer thresholds, as pro-
posed by some authors [22].
In many hospitals worldwide and in our hospital, CTPA
has become the first-line modality to exclude acute PE in
pregnant women, despite the current guidelines advocating
V/Q scanning, when available [27]. V/Q scanning following
a normal chest X-ray remains a valid approach but is today
often used as a second-line test, when CTPA is inconclusive or
contraindicated, such as in patients with renal impairment or
intolerance to iodinated contrast agents. Only 9 (3.9%) pa-
tients in our cohort underwent V/Q scanning. There are mul-
tiple reasons for the predominance of CTPA, such as the im-
mediate and widespread availability, the fast acquisition time,
the high accuracy with direct visualization of vascular emboli,
and the ability to provide alternative diagnoses [28]. This latter
point is critical and well reflected in our present study cohort,
where CTPA revealed alternative diagnoses four times more
often than the presence of PE. In a multicenter study including
512 pregnant women who underwent CTPA, van Strijen et al
found alternative diagnoses in 25% of patients, similar to our
study, consisting mostly of pneumonia [29]. In these patients,
a chest X-ray, which is usually performed before V/Q scan-
ning, would have been abnormal and, thus, casting doubt on
the added value of V/Q scanning. Indeed, according to the
most recent European guidelines, V/Q scanning is generally
not performed in such patients [30]. Radiation risk is a con-
tinuing concern, especially in the pregnant population given
the radiation sensitivity of both the fetus and the maternal
breast. Since CTPA delivers slightly lesser dose to the fetus
than V/Q scanning, but a substantially higher dose to the ma-
ternal breast tissue [31, 32], V/Q scanning following a normal
chest X-ray is still recommended by many scientific societies
[27, 33]. Either way, women subjected to ionizing radiation
should be made aware that V/Q carries a slightly higher risk of
childhood cancer than CTPA (1 in 280,000 vs. 1 in 1,000,000,
respectively), whereas CTPA is associated with a slightly in-
creased lifetime risk of breast cancer (increasing from 1 in 200
to 1.1 in 200) [34]. Even so, the radiation risks of both V/Q
Fig. 4 D-dimer boxplot
distribution in patients with and
without pulmonary embolism
(PE) detected on computed to-
mography pulmonary
angiography
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scanning and CTPA are well below the threshold for fetal
complications and should not prevent pregnant women from
receiving either imaging test [35, 36].
Finally, according to current guidelines [10], CUS of the
lower extremities was performed only in patients showing
signs and symptoms of DVT (i.e., leg pain or swelling), which
was the case in 38.4% of patients. The remaining patients
directly underwent CTPA.
Recently proposed management algorithms for acute PE
suspicion in pregnant women do no longer include chest X-
rays and focus on structuring the clinical and paraclinical
workup to appropriately select patients who will likely benefit
from CTPA [22, 23]. At our hospital, chest X-rays were
avoided in most patients (93%) to reduce radiation exposure,
based on the limited role of X-rays to drive management strat-
egies in pregnant women [9]. Among the 16 PE-positive pa-
tients, 8 (50%) had parenchymal abnormalities on CTPA, and
2 (12.5%) had pleural effusion. This substantiates the potential
diagnostic confusion that could be caused by chest X-ray in
these pregnant women, as described by Goodacre et al [9].
Our study had several limitations. First, its retrospective
nature entailed an inclusion bias that likely led to underesti-
mation of the true prevalence of PE, since a few patients may
have had positive CUS performed directly at admission due to
leg symptoms and would then have been treated without
CTPA. Second, we could not provide a comprehensive
Table 3 Characteristics, risk factors, anamnestic parameters, and symptoms—compared among the three patient groups
Variables PE positive
(n = 16)
Alternative diagnosis
(n = 69)
No findings on CTPA
(n = 144)
p value
Characteristics
Age, years 29.8 ± 5.6 32.2 ± 5.6 31.7 ± 5.9 0.27
Gestationnal age, weeks 27.3 ± 8.1 27.8 ± 7.3 27.9 ± 7.9 0.83
Anticoagulation 0 (0%) 2 (2.9%) 13 (9.0%) 0.18
Risk factors
Immobilization 2 (12.5%) 18 (26.1%) 22 (15.3%) 0.17
Obesity (BMI > 30 kg/m2) 1 (6.3%) 5 (7.2%) 19 (13.2%) 0.46
Thrombophilia 0 (0.0%) 1 (1.5%) 9 (6.3%) 0.29
Previous VTE 0 (0.0%) 1 (1.5%) 8 (5.6%) 0.43
Smoking 1 (6.3%) 8 (11.6%) 12 (8.3%) 0.75
History
Heart disease 0 (0.0%) 5 (7.2%) 4 (2.8%) 0.24
Hypertension 0 (0.0%) 6 (8.7%) 5 (3.5%) 0.21
Multiple gestations 2 (12.5%) 11 (15.9%) 15 (10.4%) 0.48
Parity 0.94 ± 1.18 0.64 ± 1.11 0.67 ± 1.02 0.38
Assisted reproductive techniques 0 (0.0%) 3 (4.3%) 2 (1.4%) 0.54
Symptoms
Chest pain 15 (93.8%) 52 (75.4%) 102 (70.8%) 0.13
Dyspnea 12 (75.0%) 57 (82.6%) 110 (76.4%) 0.55
Hemoptysis 2 (12.5%) 2 (2.9%) 4 (2.8%) 0.17
Desaturation (O2 saturation < 90%) 6‡ (37.5%) 23§ (33.3%) 20 (13.8%) 0.001
Lower extremity swelling 5° (31.3%) 6 (8.7%) 25 (17.4%) 0.045
Other parameters
Tachycardia* 5 (31.3%) 22 (34.4%) 26 (19%) 0.056
S1Q3 EKG 1 (6.3%) 5 (7.2%) 16 (11.1%) 0.71
D-dimers, ng/mL† 2238 ± 2056 1550 ± 824 1553 ± 1377 0.71
Italicized p values are statistically significant
PE pulmonary embolism, CTPA computed tomography pulmonary angiography, VTE venous thromboembolism, ECG electrocardiogram
†D-dimer levels were available for 176 patients (78.2%), including 8 with PE, 48 with an alternative diagnosis and 120 with no radiological findings
*Heart rate information was available in 218 patients (95.2%), including 16 with PE, 64 with an alternative diagnosis and 137 with no radiological
findings
§p = 0.001 compared to patients without radiological diagnosis
‡p = 0.016 compared to patients without radiological diagnosis
°p = 0.029 compared to patients with an alternative diagnosis
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radiation dose comparison between CTPA and perfusion scan-
ning. Furthermore, we had no information regarding the af-
fected side in patients with lower extremity symptoms. Heart
rate data were not available for all patients, and some women
did not undergo D-dimer testing. Finally, our low rate of PE
(7%) may have prevented us from detecting significant differ-
ences between our two groups. However, our PE prevalence
was nearly three times higher than previously described in
pregnant women [37], and nearly double compared with data
published by van der Pol et al [22]. Only Righini et al [23]
reported a similar prevalence of PE (7.1%).
In conclusion, our present study did not identify clinical
and laboratory parameters that were significantly associated
with PE, emphasizing the important role of CTPA for exclud-
ing PE in pregnant women.Moreover, our findings indicated a
low yield of PE-positive CTPA results, which suggest the
need for new diagnostic strategies to safely exclude PE with
fewer radiological examinations. However, over the last 17
years, CTPA was also able to reveal alternative diagnoses in
one third of patients, while maintaining image quality and
limiting radiation dose exposure.
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